BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niu C, Li M, Zhu S, Chen Y, Zhou L, Xu D, Li W, Cui J, Liu Y, Chen J. Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression. Front Immunol 2018;9:617. [PMID: 29632540 DOI: 10.3389/fimmu.2018.00617] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Kouakanou L, Peters C, Brown CE, Kabelitz D, Wang LD. Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy? Front Immunol 2021;12:765906. [PMID: 34899716 DOI: 10.3389/fimmu.2021.765906] [Reference Citation Analysis]
2 Weng RR, Lu HH, Lin CT, Fan CC, Lin RS, Huang TC, Lin SY, Huang YJ, Juan YH, Wu YC, Hung ZC, Liu C, Lin XH, Hsieh WC, Chiu TY, Liao JC, Chiu YL, Chen SY, Yu CJ, Tsai HC. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nat Commun 2021;12:2163. [PMID: 33846331 DOI: 10.1038/s41467-021-22433-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Silva-santos B, Mensurado S, Coffelt SB. γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat Rev Cancer 2019;19:392-404. [DOI: 10.1038/s41568-019-0153-5] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 30.3] [Reference Citation Analysis]
4 Zhao G, Wang Q, Li S, Wang X. Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism. Front Oncol 2021;11:706030. [PMID: 34650913 DOI: 10.3389/fonc.2021.706030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Luo J, Mu J, Zhang M, Zhao B, Liu L. SPAG6-silencing enhances decitabine-induced apoptosis and demethylation of PTEN in SKM-1 cells and in a xenograft mouse model. Leuk Lymphoma 2021;:1-12. [PMID: 33843428 DOI: 10.1080/10428194.2021.1913148] [Reference Citation Analysis]
6 Kalin B, van Norden Y, van Gelder M, Breems D, Maertens J, Jongen-Lavrencic M, Broers AEC, Braakman E, Grob T, Zeijlemaker W, Ossenkoppele GJ, Meijer E, Cornelissen JJ. Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation. Blood Adv 2020;4:4430-7. [PMID: 32936907 DOI: 10.1182/bloodadvances.2020002074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Hirukawa A, Singh S, Wang J, Rennhack JP, Swiatnicki M, Sanguin-Gendreau V, Zuo D, Daldoul K, Lavoie C, Park M, Andrechek ER, Westbrook TF, Harris LN, Varadan V, Smith HW, Muller WJ. Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy. Cell Rep 2019;29:249-257.e8. [PMID: 31597089 DOI: 10.1016/j.celrep.2019.08.105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
8 Kouwaki T, Nishimura T, Wang G, Oshiumi H. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses. Front Immunol 2021;12:700926. [PMID: 34249006 DOI: 10.3389/fimmu.2021.700926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tarantini F, Cumbo C, Anelli L, Zagaria A, Specchia G, Musto P, Albano F. Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia? Cancers (Basel) 2021;13:4121. [PMID: 34439275 DOI: 10.3390/cancers13164121] [Reference Citation Analysis]
10 Niu C, Li M, Zhu S, Chen Y, Zhou L, Xu D, Xu J, Li Z, Li W, Cui J. PD-1-positive Natural Killer Cells have a weaker antitumor function than that of PD-1-negative Natural Killer Cells in Lung Cancer. Int J Med Sci 2020;17:1964-73. [PMID: 32788875 DOI: 10.7150/ijms.47701] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
11 Huang C, Xiang Z, Zhang Y, Li Y, Xu J, Zhang H, Zeng Y, Tu W. NKG2D as a Cell Surface Marker on γδ-T Cells for Predicting Pregnancy Outcomes in Patients With Unexplained Repeated Implantation Failure. Front Immunol 2021;12:631077. [PMID: 33777016 DOI: 10.3389/fimmu.2021.631077] [Reference Citation Analysis]
12 An B, Zhu S, Li T, Wu J, Zang G, Lv X, Qiao Y, Huang J, Shao Y, Cui J, Liu YJ, Chen J. A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation. Front Cell Dev Biol 2020;8:262. [PMID: 32391356 DOI: 10.3389/fcell.2020.00262] [Reference Citation Analysis]